AtheroNova Inc. is a development stage company engaging in the research and development, marketing, and sale of pharmaceutical preparations and pharmaceutical intellectual property. The company develops intellectual property that uses certain pharmacological compounds for the treatment of atherosclerosis, the primary cause of various cardiovascular diseases. For more information, visit the company’s website at www.atheronova.com.